<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<ruleSet xmlns="http://semanticbits.com/rules/brxml"><id>93c92b6e-478b-4c8b-bc5c-840d3b9e8694</id><name>gov.nih.nci.cabig.caaers.rules.sponsor.study.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.cancer_therapy_evaluation_program.mandatory_sections_rules</name><description>Mandatory Sections Rules</description><subject>Sponsor defined rules for a study||Cancer Therapy Evaluation Program||Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</subject><coverage>Enabled</coverage><import>gov.nih.nci.cabig.caaers.domain.*</import><rule id="a17ecfd4-10a1-418f-86c1-cb7729180a91"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Therapy " grammer-postfix="" field-name="studyTherapy" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Drug Administration</value><readable-value>Agent,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.StudyTherapyType','studyTherapyType','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer","==")</expression></column></condition><action>AGENTS_INTERVENTION_SECTION</action><readableAction>Agents</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rules.sponsor.study.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.cancer_therapy_evaluation_program.mandatory_sections_rules" name="Rule-1" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer/cancer_therapy_evaluation_program</path><metaData name="mandatory_sections_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Therapy is  'Agent' </line></readableRule></rule><rule id="b27a8417-8e5b-462e-a88f-e35157a1a273"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.report.ReportDefinition" identifier="reportDefinition" display-uri="Report Definition"><field-constraint grammer-prefix=" Report Definition " grammer-postfix="" field-name="reportDefinitionName" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Commercial Intervention 3 Day Report</value><value>Commercial Intervention 7 Day AdEERS Report</value><value>Commercial Intervention 24 Hour SAE Notification</value><value>Non-CTEP IND 3 Day Expedited Report</value><value>Non-CTEP IND 7 Calendar Day Report</value><value>Non-CTEP IND 24 Hour SAE Notification</value><value>CTEP 24 Hour SAE Notification</value><value>CTEP 10 Calendar Day SAE Report</value><value>CTEP 5 Calendar Day SAE Report</value><value>CTEP Commercial Intervention SAE Report</value><readable-value>Commercial Intervention 3 Day Report,Commercial Intervention 7 Day AdEERS Report,Commercial Intervention 24 Hour SAE Notification,Non-CTEP IND 3 Day Expedited Report,Non-CTEP IND 7 Calendar Day Report,Non-CTEP IND 24 Hour SAE Notification,CTEP 24 Hour SAE Notification,CTEP 10 Calendar Day SAE Report,CTEP 5 Calendar Day SAE Report,CTEP Commercial Intervention SAE Report</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(reportDefinition,null,'name','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer","==")</expression></column></condition><action>BASICS_SECTION</action><action>ADVERSE_EVENT_SECTION</action><action>REPORTER_INFO_SECTION</action><action>DESCRIPTION_SECTION</action><action>STUDY_INTERVENTIONS</action><action>MEDICAL_INFO_SECTION</action><action>TREATMENT_INFO_SECTION</action><action>ATTRIBUTION_SECTION</action><action>SUBMIT_REPORT_SECTION</action><readableAction>Adverse Events</readableAction><readableAction>Adverse Events</readableAction><readableAction>Reporter</readableAction><readableAction>Describe Event</readableAction><readableAction>Study Interventions</readableAction><readableAction>Subject Details</readableAction><readableAction>Course</readableAction><readableAction>Attribution</readableAction><readableAction>Review &amp; Submit</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rules.sponsor.study.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.cancer_therapy_evaluation_program.mandatory_sections_rules" name="Rule-2" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer/cancer_therapy_evaluation_program</path><metaData name="mandatory_sections_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Report Definition is  'Commercial Intervention 3 Day Report'  or 'Commercial Intervention 7 Day AdEERS Report'  or 'Commercial Intervention 24 Hour SAE Notification'  or 'Non-CTEP IND 3 Day Expedited Report'  or 'Non-CTEP IND 7 Calendar Day Report'  or 'Non-CTEP IND 24 Hour SAE Notification'  or 'CTEP 24 Hour SAE Notification'  or 'CTEP 10 Calendar Day SAE Report'  or 'CTEP 5 Calendar Day SAE Report'  or 'CTEP Commercial Intervention SAE Report' </line></readableRule></rule><rule id="a8d44410-f8a7-49cc-a527-96d01eb1bbb5"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Therapy " grammer-postfix="" field-name="studyTherapy" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Device</value><readable-value>Device,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.StudyTherapyType','studyTherapyType','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer","==")</expression></column></condition><action>MEDICAL_DEVICE_SECTION</action><readableAction>Device</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rules.sponsor.study.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.cancer_therapy_evaluation_program.mandatory_sections_rules" name="Rule-3" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer/cancer_therapy_evaluation_program</path><metaData name="mandatory_sections_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Therapy is  'Device' </line></readableRule></rule><rule id="02c1f6d7-99f3-43ad-b88e-7228bc89132d"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Therapy " grammer-postfix="" field-name="studyTherapy" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Radiation</value><readable-value>Radiation,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.StudyTherapyType','studyTherapyType','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer","==")</expression></column></condition><action>RADIATION_INTERVENTION_SECTION</action><readableAction>Radiation</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rules.sponsor.study.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.cancer_therapy_evaluation_program.mandatory_sections_rules" name="Rule-4" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer/cancer_therapy_evaluation_program</path><metaData name="mandatory_sections_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Therapy is  'Radiation' </line></readableRule></rule><rule id="ab1725f0-78b5-4b96-b1f7-c8e492d0538c"><condition><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="study" display-uri="Study"><field-constraint grammer-prefix=" Study Therapy " grammer-postfix="" field-name="studyTherapy" display-uri="undefined"><literal-restriction evaluator="==" display-uri="is "><value>Surgery</value><readable-value>Surgery,</readable-value></literal-restriction></field-constraint><expression>factResolver.assertFact(study,'gov.nih.nci.cabig.caaers.domain.StudyTherapyType','studyTherapyType','runTimeValue','runTimeOperator')</expression></column><column object-type="com.semanticbits.rules.objectgraph.FactResolver" identifier="factResolver"><field-constraint><literal-restriction/></field-constraint></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="primarySponsorCode"><literal-restriction evaluator="=="><value>Cancer Therapy Evaluation Program</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,"gov.nih.nci.cabig.caaers.domain.Organization","name","Cancer Therapy Evaluation Program","==")</expression></column><column object-type="gov.nih.nci.cabig.caaers.domain.Study" identifier="studySDO"><field-constraint field-name="shortTitle"><literal-restriction evaluator="=="><value>Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer</value></literal-restriction></field-constraint><expression>factResolver.assertFact(studySDO,null,"shortTitle","Phase II Trial of Albumin-Bound Paclitaxel in Combination with Gemcitabine and Bevacizumab in Patients with Metastatic Breast Cancer","==")</expression></column></condition><action>SURGERY_INTERVENTION_SECTION</action><readableAction>Surgery</readableAction><metaData packageName="gov.nih.nci.cabig.caaers.rules.sponsor.study.phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer.cancer_therapy_evaluation_program.mandatory_sections_rules" name="Rule-5" description="Setting Description since its mandatory by JBoss Repository config" checkinComment="Initial Version"><category><path>CAAERS_BASE/SPONSOR_DEFINED_STUDY/phase_ii_trial_of_albumin_bound_paclitaxel_in_combination_with_gemcitabine_and_bevacizumab_in_patients_with_metastatic_breast_cancer/cancer_therapy_evaluation_program</path><metaData name="mandatory_sections_rules"/></category></metaData><readableRule><line>IF</line><line>	 &amp;nbsp;&amp;nbsp;&amp;nbsp; Study Therapy is  'Surgery' </line></readableRule></rule></ruleSet>

